Mereo BioPharma (AgeTech UK) Biomed
Kinase inhibitors and other in pipeline for various, inclusing COPD. Mission is to provide new therapies to patients with chronically debilitating and life limiting rare diseases that have few, if any, other treatment options.
Technology:
AgeTech Companies
Funding Status:
N/A
Number Of Exists:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Employee Number:
N/A
Headquarters:
United Kingdom
Founded Date:
N/A
Industry:
UK AgeTech 2020